Long term outcomes of 176 patients with X-linked hyper IgM syndrome treated with or without hematopoietic cell transplantation

Long term outcomes of 176 patients with X-linked hyper IgM syndrome treated with or without hematopoietic cell transplantation

BACKGROUND: X-linked hyper IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity and mortality compared to normal individuals. Hematopoietic cell transplant (HCT) has been considered a curative therapy, but the procedure has inherent complications, and may not be available for all...

Full description

Bibliographic Details
Main Authors: de la Morena, M, Leonard, D, Torgerson, T, Cabral-Marques, O, Slatter, M, Aghamohammadi, A, Chandra, S, Murguia-Favela, L, Bonilla, F, Kanariou, M, Damrongwatanasuk, R, Kuo, C, Dvorak, C, Meyts, I, Chen, K, Kobrynski, L, Kapoor, N, Richter, D, DiGiovanni, D, Dhalla, F, Farmaki, E, Speckmann, C, Espanol, T, Shcherbina, A, Hanson, C, Litzman, J, Routes, J, Wong, M, Fuleihan, R, Seneviratne, S, Small, T, Janda, A, Bezrodnik, L, Seger, R, Raccio, A, Edgar, J, Chou, J, Abbott, J, van Montfrans, J, Gonzalez-Granado, L, Bunin, N, Kutukculer, N, Gray, P, Seminario, G, Pasic, S, Aquino, V, Wysocki, C, Abolhassani, H, Grunebaum, E, Dorsey, M, Costa Carvalho, B, Condino-Neto, A, Cunningham-Rundles, C, Knutsen, A, Sleasman, J, Chapel, H, Ochs, H, Filipovich, A, Cowan, M, Gennery, A, Cant, A, Notarangelo, L, Roifman, C
Format: Journal article
Language:English
Published: Elsevier 2016

Similar Items